Oral Ibrexafungerp: an investigational agent for the treatment of vulvovaginal candidiasis.

Vulvovaginal candidiasis (VVC) is a common fungal infection caused by predominantly Candida albicans, and is diagnosed in up to 40% of women with vaginal complaints in the primary care setting. App...